Sort   by:  
 Page size 
TranscriptomicsTranscription profiling by array of human colorectal cancer epithelial (HCT116) p53 null cells treated with SN38 for 6, 12 and 24h
HCT116 p53 null cells were treated with 5nM SN38 (active metabolite of CPT-11) for 6, 12 and 24h. Following this RNA was harvested for transcriptional profiling.
ORGANISM(S): Homo sapiens 
2007-11-30 | E-MEXP-1194 | biostudies-arrayexpress
UnknownChemotherapy-induced activation of ADAM-17: a novel mechanism of drug resistance in colorectal cancer.
Not available
S-EPMC2896550 | biostudies-literature
UnknownSrc and ADAM-17-mediated shedding of transforming growth factor-alpha is a mechanism of acute resistance to TRAIL.
Not available
S-EPMC2596349 | biostudies-literature
UnknownOncogenic Kras promotes chemotherapy-induced growth factor shedding via ADAM17.
Not available
S-EPMC3073126 | biostudies-literature
UnknownA Nudibranch Marine Extract Selectively Chemosensitizes Colorectal Cancer Cells by Inducing ROS-Mediated Endoplasmic Reticulum Stress.
Not available
S-EPMC8388012 | biostudies-literature
UnknownConnectivity Mapping for Candidate Therapeutics Identification Using Next Generation Sequencing RNA-Seq Data.
Not available
S-EPMC3694114 | biostudies-literature
UnknownTRAIL signaling promotes entosis in colorectal cancer.
Not available
S-EPMC8563286 | biostudies-literature
UnknownPharmacogenomic profiling and pathway analyses identify MAPK-dependent migration as an acute response to SN38 in p53 null and p53-mutant colorectal cancer cells.
Not available
S-EPMC3428848 | biostudies-literature
UnknownRepurposing of Cetuximab in antibody-directed chemotherapy-loaded nanoparticles in EGFR therapy-resistant pancreatic tumours.
Not available
S-EPMC6861736 | biostudies-literature
UnknownHDAC Inhibition Overcomes Acute Resistance to MEK Inhibition in BRAF-Mutant Colorectal Cancer by Downregulation of c-FLIPL.
Not available
S-EPMC4504978 | biostudies-literature
Sort   by:  
 Page size